Targeting the reduction of inflammatory risk associated with cardiovascular disease by treating periodontitis either alone or in combination with a systemic anti-inflammatory agent: protocol for a pilot, parallel group, randomised controlled trial

INTRODUCTION: Cardiovascular disease (CVD) is associated with systemic inflammation. Colchicine, an anti-inflammatory drug, reduces the incidence of CVD events. Periodontitis, a chronic localised inflammatory disease of the tissues supporting the teeth, triggers systemic inflammation and contributes...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Shalinie, Church, Lauren, Garde, Siddharth, Chow, Clara K, Akhter, Rahena, Eberhard, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Dentistry and Oral Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680180/
https://www.ncbi.nlm.nih.gov/pubmed/36410825
http://dx.doi.org/10.1136/bmjopen-2022-063148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680180/
https://www.ncbi.nlm.nih.gov/pubmed/36410825
http://dx.doi.org/10.1136/bmjopen-2022-063148

Ejemplares similares